Unknown

Dataset Information

0

Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study.


ABSTRACT: OBJECTIVE:Understand how insurance impacts access to services among people who have injected drugs. METHODS:1748 adults who have injected drugs were assessed at twice-annual study visits between 2006 and 2017 (18,869 visits). Use of specialty substance use treatment, receipt of buprenorphine, and having a regular source of medical care were assessed for association with concurrent insurance coverage. Random intercept logistic regression was used to adjust for potential confounders. RESULTS:When participants acquired insurance, they were more likely to report specialty substance use treatment (aOR 2.0, 95% CI 1.6 to 2.5), a buprenorphine prescription (aOR 3.3, 95% CI 2.0 to 5.5), and a regular source of medical care (aOR 6.3, 95% CI 5.1 to 7.8). CONCLUSION:Insurance is associated with increased use of three important services for individuals who inject drugs. IMPLICATIONS:Expanding insurance may facilitate access to substance use treatment and other needed health services.

SUBMITTER: Feder KA 

PROVIDER: S-EPMC6556110 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study.

Feder Kenneth A KA   Krawczyk Noa N   Mojtabai Ramin R   Crum Rosa M RM   Kirk Gregory G   Mehta Shruti H SH  

Journal of substance abuse treatment 20180828


<h4>Objective</h4>Understand how insurance impacts access to services among people who have injected drugs.<h4>Methods</h4>1748 adults who have injected drugs were assessed at twice-annual study visits between 2006 and 2017 (18,869 visits). Use of specialty substance use treatment, receipt of buprenorphine, and having a regular source of medical care were assessed for association with concurrent insurance coverage. Random intercept logistic regression was used to adjust for potential confounders  ...[more]

Similar Datasets

| S-EPMC4189808 | biostudies-literature
| S-EPMC5308462 | biostudies-literature
| S-EPMC8211364 | biostudies-literature
| S-EPMC8726008 | biostudies-literature
| S-EPMC4117395 | biostudies-literature
| S-EPMC8011294 | biostudies-literature
| S-EPMC6341207 | biostudies-literature
| S-EPMC6395562 | biostudies-literature
| S-EPMC2881060 | biostudies-literature
| S-EPMC8139823 | biostudies-literature